Cover Image

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis

Background: Combination therapy has become an attractive option in pulmonary arterial hypertension (PAH) treatment. The aim of this study was to investigate whether additional use of prostacyclin analogs could exert any additional benefits over background targeted therapies in PAH patients.Methods:...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pengwei Wang (Author), Jiaxin Deng (Author), Quanying Zhang (Author), Hongyan Feng (Author), Yongheng Zhang (Author), Yizhong Lu (Author), Lizhu Han (Author), Pengfei Yang (Author), Zhijian Deng (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study
by: Bonnie B. Dean, et al.
Published: (2020)

The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
by: Kevin P. Cunningham, et al.
Published: (2021)

Correction to: Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study
by: Bonnie B. Dean, et al.
Published: (2020)

Prostacyclin: An inflammatory paradox.
by: Jeremiah eStitham, et al.
Published: (2011)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024)

Effects Of Prostacyclın In Osteoclastıc Actıvatıon
by: Yalçın Işımer, et al.
Published: (1990)

Inhaled prostacyclin for Eisenmenger syndrome complicated with miliary tuberculosis
by: Eva M. Marwali, et al.
Published: (2011)

Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
by: Jingwen Xia, et al.
Published: (2018)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
by: Li Gu, et al.
Published: (2020)

Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury
by: An Y, et al.
Published: (2014)

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
by: Qi Jin, et al.
Published: (2023)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
by: Burger CD, et al.
Published: (2024)

NADPH Oxidase 4: Crucial for Endothelial Function under Hypoxia-Complementing Prostacyclin
by: Heike Brendel, et al.
Published: (2024)

Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Alexis Coulis, et al.
Published: (2024)

Genetics and Genomics of Pulmonary Arterial Hypertension
Published: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension
by: Brian Casserly, et al.
Published: (2008)

Proteomic analysis of pulmonary arterial hypertension
by: Xiaohan Qin, et al.
Published: (2021)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022)

The effect of honokiol on pulmonary artery endothelium cell autophagy mediated by cyclophilin A in hypoxic pulmonary arterial hypertension
by: Xiaoying Wang, et al.
Published: (2019)

Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension
by: Ruhao Wu, et al.
Published: (2024)

Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
by: Bodil Ivarsson, et al.
Published: (2014)

Pulmonary arteriovenous malformations with pulmonary artery hypertension: Therapeutic implication
by: Jayachandra, et al.
Published: (2020)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
by: Wenxing Dong, et al.
Published: (2023)

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review
by: Xiaoxian Deng, et al.
Published: (2020)

Imaging Diagnosis of Anomalous Total Coronary Artery From the Pulmonary Artery: Case Report
by: Rongchuan Ma, et al.
Published: (2021)

Principles of pharmacological correction of pulmonary arterial hypertension
by: Mikhail Korokin, et al.
Published: (2018)

Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024)

Novel and emerging therapies in pulmonary arterial hypertension
by: Steven J. Cassady, et al.
Published: (2022)

Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
by: Naoyuki Otani, et al.
Published: (2022)

Quality of life in patients with pulmonary arterial hypertension
by: Mirosława Anna Kowalkowska, et al.
Published: (2023)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
by: Jina Yeo, et al.
Published: (2022)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
by: Huayang Li, et al.
Published: (2021)

Echinacoside prevents hypoxic pulmonary hypertension by regulating the pulmonary artery function
by: Xiangyun Gai, et al.
Published: (2020)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
by: Fotini Ampatzidou, et al.
Published: (2023)

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure
by: Feng JQ, et al.
Published: (2016)

Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension
by: Anqi Duan, et al.
Published: (2022)

Chapter Hypoxic Pulmonary Arterial Hypertension in the Chicken Model
by: de Sandino, Martha
Published: (2011)

Chapter Hypoxic Pulmonary Arterial Hypertension in the Chicken Model
by: de Sandino, Martha
Published: (2011)

Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
by: Zolty R
Published: (2021)